Skip to main content
SpringerLink
Log in

Serum Interleukin-11 in Patients with Benign Prostatic Hyperplasia and Prostate Cancer

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

To clarify whether serum levels of interleukin-11 (IL-11) could be a useful marker in patients with prostate cancer, serum IL-11 was determined in 73 and 23 men with prostate cancer and benign prostate hyperplasia (BPH), respectively, before treatment. There were no statistical differences of IL-11 levels between patients with prostate cancer and BPH. Patients with hormone-resistant prostate cancer had a significantly higher level of IL-11 than those with untreated cancer. Serum IL-11 levels may be a potential tumor marker for prostate cancer progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. DA. DuX Williams (1997) ArticleTitleInterleukin-11: review of molecular, cell biology, and clinical use Blood 89 3897 Occurrence Handle9166826

    PubMed  Google Scholar 

  2. G Girasole G Passeri RL Jilka SC. Manolagas (1994) ArticleTitleInterleukin-11: a new cytokine critical for osteoclast development J Clin Invest 93 1516 Occurrence Handle8163655

    PubMed  Google Scholar 

  3. S Akimoto A Okumura H. Fuse (1998) ArticleTitleRelationship between serum levels of interleukin-6, tumor necrosis factor-α and bone turnover markers in prostate cancer patients Endocrine J 45 183

    Google Scholar 

  4. J Nakashima M Tachibana Y Horiguchi et al. (2000) ArticleTitleSerum interleukin-6 as a prognostic factor in patients with prostate cancer Clin Cancer Res 6 2702 Occurrence Handle10914713

    PubMed  Google Scholar 

  5. M Lacroix B Siwek PJ Marie J. Body (1998) ArticleTitleProduction and regulation of interleukin-11 by breast cancer cells Cancer Lett 127 29 Occurrence Handle10.1016/S0304-3835(97)00542-9 Occurrence Handle9619855

    Article  PubMed  Google Scholar 

  6. C Sotiriou M Lacroix L Lespagnard et al. (2001) ArticleTitleInterleukins-6 and −11 expression in primary breast cancer and subsequent development of bone metastases Cancer Lett 169 87 Occurrence Handle10.1016/S0304-3835(01)00524-9 Occurrence Handle11410329

    Article  PubMed  Google Scholar 

  7. CL Campbell Z Jiang DMF Savarese TM. Savarese (2001) ArticleTitleIncreased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma Am J Pathol 158 25 Occurrence Handle11141475

    PubMed  Google Scholar 

  8. T Yin YC. Yang (1993) ArticleTitleProtein tyrosine phosphorylation and activation of primary response genes by interleukin 11 in B9-TY1 cells Cell Growth Diff 4 603 Occurrence Handle8398901

    PubMed  Google Scholar 

  9. FJ Hughes GL. Howells (1993) ArticleTitleInterleukin-11 inhibits bone formation in vitro Calcif Tissue Int 53 362 Occurrence Handle10.1007/BF01351844 Occurrence Handle8287326

    Article  PubMed  Google Scholar 

  10. T. Kishimoto (1989) ArticleTitleThe biology of interleukin-6 Blood 74 1 Occurrence Handle2473791

    PubMed  Google Scholar 

  11. B Knoefel K Nuske T Steiner et al. (1997) ArticleTitleRenal cell carcinomas produce IL-6, IL-10, IL-11, and TGF-b1 in primary cultures and modulate T lymphocyte blast transformation J Interferon Cytokine Res 17 95 Occurrence Handle9058315

    PubMed  Google Scholar 

  12. T Matsuda A Junicho T Yamamoto et al. (2001) ArticleTitleCross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells Biochem Biophys Res Commun. 2001 IssueID283 179 Occurrence Handle10.1006/bbrc.2001.4758

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Ichihara Hospital, Teikyo University School of Medicine, 3426-3, Anesaki, Ichihara, 299-0111, Japan

    Yuzo Furuya

  2. Department of Urology, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan

    Remon Nishio, Akira Junicho, Osamu Nagakawa & Hideki Fuse

Authors
  1. Yuzo Furuya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Remon Nishio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akira Junicho
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Osamu Nagakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hideki Fuse
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuzo Furuya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Furuya, Y., Nishio, R., Junicho, A. et al. Serum Interleukin-11 in Patients with Benign Prostatic Hyperplasia and Prostate Cancer. Int Urol Nephrol 37, 69–71 (2005). https://doi.org/10.1007/s11255-004-6086-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-004-6086-1

Keywords

Search

Navigation